netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Search
 Results

Looking for Doxorubicin found 10 matches

Open monograph to display formulary status BNF Category
  Cytotoxic Drug Doxorubicin Malignant disease and immunosuppression - Anthracyclines and other cytotoxic antibiotics - 08.01.02
  Cytotoxic Drug Restricted Drug Pegylated-liposomal Doxorubicin  (Caelyx) Malignant disease and immunosuppression - Anthracyclines and other cytotoxic antibiotics - 08.01.02
  Cytotoxic Drug Restricted Drug Trabectedin  (Yondelis) Malignant disease and immunosuppression - Trabectedin - 08.01.05
 
Non Formulary BNF Category
  Olaratumab  (Lartruvo) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.02)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.03)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer (08.01.05)
link in drug section NICE TA465: Olaratumab in combination with doxorubicin for treating advanced soft tissue sarcoma (08.01.02)


 

netFormulary